Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB17421InvestigationalSmall molecule
Trotabresib is an oral, potent, and reversible inhibitor of the epigenetic target bromodomain and extra-terminal (BET) proteins.
- Mechanism
- Curator reviewed
Pharmacologically active on Bromodomain-containing protein 4, Bromodomain-containing protein 3, and Bromodomain-containing protein 7
- Also known as
- 1(2h)-isoquinolinone, 4-(2-(cyclopropylmethoxy)-5-(methylsulfonyl)phenyl)-2-methyl- · 4-(2-(cyclopropylmethoxy)-5-methylsulfonylphenyl)-2-methylisoquinolin-1-one · Bet inhibitor cc-90010
- Code names
- BMS-986378 · CC-90010
Resolves to
Compound
What you can answer from here — as of November 03, 2026
Which drugs share a target with Trotabresib, and which of those have an active Phase 3 trial?